StockWatch
·

Surgery Partners, Inc. Q3 FY26 Results

SGRYQ3 FY26 Results
Filing
MetricValue ($ M)Q2 FY26Q3 FY25
Revenue815.304.0%0.8%
Total Income815.304.0%0.8%
Expenditure729.702.3%1.9%
PBT—
Net Profit-21.1040.7%7.0%
OPM10.50%1.53pp2.37pp
NPM-2.59%0.82pp0.17pp
EPS-0.1633.3%11.1%
View full financials

Surgery Partners Announces Q3 2026 Results

10 Nov 2026 · 10 Nov, 2:47 am

Summary

Surgery Partners, Inc. announced its third quarter 2026 results, reporting a revenue decrease of 0.8% to $815.3 million, while same-facility revenues saw a 6.0% increase. The company reported a net loss of $21.1 million and Adjusted EBITDA of $132.7 million for the quarter. Year-to-date, revenues grew 2.1% to $2,475.1 million, with Adjusted EBITDA at $360.2 million. The company noted that forward-looking guidance will not be provided due to the pending transaction with HealthSpan Partners.

Key Highlights

  1. 1

    Revenue decreased by 0.8% to $815.3 million for the third quarter of 2026 compared to the prior year period.

  2. 2

    Same-facility revenues increased by 6.0% for the third quarter of 2026.

  3. 3

    Same-facility cases increased by 0.2% for the third quarter of 2026.

  4. 4

    Net loss attributable to Surgery Partners, Inc. was $21.1 million for the third quarter of 2026.

  5. 5

    Adjusted EBITDA was $132.7 million for the third quarter of 2026.

  6. 6

    Year-to-date revenues increased 2.1% to $2,475.1 million for the first nine months of 2026.

  7. 7

    Year-to-date Adjusted EBITDA was $360.2 million for the first nine months of 2026.

Management Comments

E

Eric Evans

Our financial results in the third quarter reflect the impact of the successful Idaho Falls divestiture and sustained momentum in our core business, underscoring the value of our short-stay surgical platform. Additionally, the recently announced amended merger agreement with HealthSpan Partners serves as further validation of our unique offering, while representing a compelling outcome for our patients, physicians, stockholders, and other stakeholders. We are excited to move forward with this next chapter as we continue to deliver high-quality care to all our patients and support our physicians, colleagues and health system partners.

Informational and educational content only. Not investment advice.